Literature DB >> 12048139

Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia.

Saskia de Jongh1, Marc R Lilien, Henk D Bakker, Barbara A Hutten, John J P Kastelein, Erik S G Stroes.   

Abstract

OBJECTIVES: in patients with familial hypercholesterolemia (FH), the propensity towards atherosclerosis may vary considerably. In the general population, a positive family history is associated with an increased risk for cardiovascular events. Since endothelial dysfunction is predictive for future cardiovascular events, we evaluated whether FH-children with a positive family history of premature cardiovascular disease have more pronounced endothelial dysfunction compared to children with a negative family history. STUDY
DESIGN: 50 FH children, 10-18 years, participated in this study. Thirty-one children had a positive family history for cardiovascular events (fh(+)) and 19 children had no events in the family (fh(-)). Nineteen matched siblings participated as controls. Endothelial function was assessed by testing the flow mediated dilatation (FMD) of the brachial artery.
RESULTS: baseline characteristics were comparable for fh(+), fh(-) and controls. Lipid levels were significantly higher in FH children. In FH, FMD was impaired compared to controls (11.7+/-4.4 vs. 15.6+/-6.8%, P<0.03). In addition, FMD was significantly lower in fh(+) compared to fh(-) (10.7+/-9.9 vs. 13.3+/-4.6%, P<0.05).
CONCLUSION: In FH-children, endothelial function is impaired compared to matched controls. This impairment is most pronounced in FH children with a positive family history of premature cardiovascular disease.

Entities:  

Mesh:

Year:  2002        PMID: 12048139     DOI: 10.1016/s0021-9150(02)00003-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  28 in total

1.  Steady-state pharmacokinetics of pravastatin in children with familial hypercholesterolaemia.

Authors:  Heleen E Wiersma; Albert Wiegman; Richard P Koopmans; Henk D Bakker; John J P Kastelein; Chris J van Boxtel
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

2.  Prior cycling exercise does not prevent endothelial dysfunction after resistance exercise.

Authors:  Takuma Morishima; Masahira Toyoda; Eisuke Ochi
Journal:  Eur J Appl Physiol       Date:  2019-05-04       Impact factor: 3.078

Review 3.  Progress and perspectives in plant sterol and plant stanol research.

Authors:  Peter J H Jones; Maryam Shamloo; Dylan S MacKay; Todd C Rideout; Semone B Myrie; Jogchum Plat; Jean-Baptiste Roullet; David J Baer; Kara L Calkins; Harry R Davis; P Barton Duell; Henry Ginsberg; Helena Gylling; David Jenkins; Dieter Lütjohann; Mohammad Moghadasian; Robert A Moreau; David Mymin; Richard E Ostlund; Rouyanne T Ras; Javier Ochoa Reparaz; Elke A Trautwein; Stephen Turley; Tim Vanmierlo; Oliver Weingärtner
Journal:  Nutr Rev       Date:  2018-10-01       Impact factor: 7.110

4.  Effects of 5 % weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial.

Authors:  Ana Paula Trussardi Fayh; André Luiz Lopes; Antônio Marcos Vargas da Silva; Alvaro Reischak-Oliveira; Rogério Friedman
Journal:  Eur J Nutr       Date:  2012-10-07       Impact factor: 5.614

5.  HUVECs from newborns with a strong family history of myocardial infarction overexpress adhesion molecules and react abnormally to stimulating agents.

Authors:  A Paez; A R Méndez-Cruz; E Varela; E Rodriguez; J Guevara; L Flores-Romo; L F Montaño; F A Massó
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 6.  Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

Authors:  Jonathan Wagner; J Steven Leeder
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

Review 7.  Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.

Authors:  Anthony S Wierzbicki; Adie Viljoen
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 8.  Established and recently identified coronary heart disease risk factors in young people: the influence of physical activity and physical fitness.

Authors:  Non Eleri Thomas; Julien S Baker; Bruce Davies
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

9.  Management of Hyperlipidemia in the Pediatric Population.

Authors:  Serena Tonstad; Gilbert R. Thompson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

10.  Arterial stiffness in the young: assessment, determinants, and implications.

Authors:  Yiu-Fai Cheung
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.